PREFER

development of a bio-compatible product for the therapy of difficult wounds

START

05 NOVEMBER 2018

END

05 MAY 2021

THE PROBLEM

Difficult wounds (diabetic foot, ulcers) are serious pathologies that can lead to amputation and are very common in the elderly population.

OBJECTIVES

The aim of PREFER is to improve existing therapies for the healing of difficult wounds by developing an innovative product based on the combination of an extracellular matrix, autologous endothelial cells and growth factors to stimulate the formation of blood vessels and the regrowth of the skin epithelium.

Poster

Download here the poster

This project is funded by:

Programma Operativo del Fondo europeo di sviluppo regionale 2014-2020 del Friuli Venezia Giulia.